Actualités XOMA Royalty Corporation - XOMA | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-05-18 2022-05-18 0000791908 us-gaap:CommonStockMember 2022-05-18 2022-05-18 0000791908...

XOMA to Present at H.C. Wainwright Global Investment Conference

EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty...

Quarterly Report (10-q)

22800007373000364800079030000.320.7011330000112400003648000790300011330000112400000.320.7011409935113152630000791908--12-312022Q1false9840009840005...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-05-05 2022-05-05 0000791908 us-gaap:CommonStockMember 2022-05-05 2022-05-05 0000791908...

XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events

Earned a $2 million milestone from Rezolute as it dosed the final patient in a Phase 2 open-label study of...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the...

XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference

EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-03-08 2022-03-08 0000791908 us-gaap:CommonStockMember 2022-03-08 2022-03-08 0000791908...

Annual Report (10-k)

00007919082021FYfalse000098400098400000000050035003NoNoYesYes98400098400098400016000500350035003112287921131526315798000132980000.02370000000000000...

XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events

Earned $35 million milestone payment as NIS793 entered Phase 3 clinical study in metastatic pancreatic cancer...

XOMA to Present at the 42nd Annual Cowen Health Care Conference

EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

XOMA Actualités

Current Report Filing (8-k)

XOMA to Present at H.C. Wainwright Global Investment Conference

Quarterly Report (10-q)

Current Report Filing (8-k)

XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events

Additional Proxy Soliciting Materials (definitive) (defa14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

XOMA Declares Quarterly Preferred Stock Dividends

XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference

Current Report Filing (8-k)

Annual Report (10-k)

XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events

XOMA to Present at the 42nd Annual Cowen Health Care Conference

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

XOMA Royalty Corporation (XOMA) Actualités

XOMA Royalty Corporation (XOMA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

XOMA Actualités

Current Report Filing (8-k)

XOMA to Present at H.C. Wainwright Global Investment Conference

Quarterly Report (10-q)

Current Report Filing (8-k)

XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events

Additional Proxy Soliciting Materials (definitive) (defa14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

XOMA Declares Quarterly Preferred Stock Dividends

XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference

Current Report Filing (8-k)

Annual Report (10-k)

XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events

XOMA to Present at the 42nd Annual Cowen Health Care Conference

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités